HALOZYME THERAPEUTICS INC 4
4 · HALOZYME THERAPEUTICS INC · Filed Mar 23, 2007
Insider Transaction Report
Form 4
Yocum Richard C
VP Clinical Development
Transactions
- Exercise/Conversion
Common Stock
2007-03-21$1.87/sh+29,858$55,834→ 29,858 total - Sale
Common Stock
2007-03-22$8.46/sh−300$2,538→ 95,533 total - Exercise/Conversion
Option to Purchase Common Stock
2007-03-21$1.87/sh−29,858$55,834→ 188,118 totalExercise: $1.87From: 2005-05-12Exp: 2015-05-12→ Common Stock (29,858 underlying) - Sale
Common Stock
2007-03-22$8.50/sh−17,900$152,150→ 69,075 total - Sale
Common Stock
2007-03-22$8.52/sh−2,600$22,152→ 66,475 total - Sale
Common Stock
2007-03-22$8.45/sh−8,300$70,135→ 87,233 total - Exercise/Conversion
Common Stock
2007-03-21$1.87/sh+65,975$123,373→ 95,833 total - Sale
Common Stock
2007-03-22$8.63/sh−200$1,726→ 65,975 total - Exercise/Conversion
Option to Purchase Common Stock
2007-03-21$1.87/sh−65,975$123,373→ 122,143 totalExercise: $1.87From: 2005-05-12Exp: 2015-05-12→ Common Stock (65,975 underlying) - Sale
Common Stock
2007-03-22$8.49/sh−100$849→ 86,975 total - Sale
Common Stock
2007-03-22$8.47/sh−158$1,338→ 87,075 total